Swiss Nordic Bio is a high-level partnering and investor conference aimed at connecting healthcare innovations, investors and industry. The event carries 13 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss partners. Business Sweden and Vator Securities are the co-hosts of this year’s digital version of this event.
"It will be very interesting to meet with European participants to assess how Calmark is perceived in an international investor context”, says Anna Söderlund, CEO. "In the private placement at the end of last year, several Danish and Norwegian actors chose to invest in Calmark and I look forward to welcoming more!”
Find out more about the event: https://www.swissnordicbio.com